| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $1,886,369 ) |
| | 2023 | 2023 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01AR077962 | MicroRNA regulation of osteoblast physiology and glucocorticoid signaling | 001 | 2 | NIH | 11/10/2022 | $107,214 |
| | 2023 | 2023 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01AR077534 | Studies of Osteoclast Lineage in Health and Diseases | 000 | 3 | NIH | 11/14/2022 | $392,314 |
| | 2023 | 2023 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R21AI159592 | Braking Macrophage Cell-Cell Fusion in the Foreign Body Response | 000 | 2 | NIH | 10/24/2022 | $246,000 |
| | 2023 | 2023 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01NS111986 | Regulation of synaptic plasticity by BDNF-endocannabinoid interactions | 000 | 4 | NIH | 11/24/2022 | $486,967 |
| | 2023 | 2023 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01AI173305 | Impact of Senolytics on Aged Vaccine Responses | 000 | 1 | NIH | 11/1/2022 | $412,500 |
| | 2023 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R21HD107354 | Development of a culturally informed method of evaluating emotion socialization within Latino families | 000 | 1 | NIH | 10/27/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | U01HL156349 | SCGE Disease Models Studies Supplement: Cardioediting Ttntvs in a humanized mouse model | 000 | 4 | NIH | 11/2/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R35GM138319 | Scope and mechanism of coordinated alternative splicing and alternative polyadenylation | 001 | 4 | NIH | 11/23/2022 | $283,091 |
| | 2023 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | U01DE028520 | Individualized Assessment and Treatment Program for TMD: Coping as a Mechanism | 000 | 3 | NIH | 11/28/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | U7701068 | Model State-Supported Area Health Education Centers | 01 | 20 | HRSA | 11/8/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | U19AI144177 | A Global Syphilis Vaccine Targeting Outer Membrane Proteins of Treponema pallidum. | 000 | 4 | NIH | 11/16/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R24DA057632 | Collaborative Hub for Emerging Adult Recovery Research (CHEARR) | 000 | 1 | NIH | 10/24/2022 | $0 |
| | 2023 | 2021 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01AR077962 | MicroRNA regulation of osteoblast physiology and glucocorticoid signaling | 000 | 1 | NIH | 10/27/2022 | $0 |
| | 2023 | 2021 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R21CA245602 | Tumor-specific activation of transgene expression by Scd3 locus | 000 | 2 | NIH | 11/29/2022 | $0 |
| | 2023 | 2021 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R21CA237920 | Saturation genome editing approach to functionally test all possible MSH2 variants | 000 | 2 | NIH | 11/29/2022 | $0 |
| | 2023 | 2021 | UNIVERSITY OF CONNECTICUT | 263 farmington ave, asb #3 | farmington | CT | 06032-1956 | HARTFORD | USA | 90DDUC0071 | University of Connecticut A.J. Pappanikou Center for Excellence in Developmental Disabilities Education, Research, and Service | 01 | 5 | ACL | 11/16/2022 | $0 |
| | 2023 | 2020 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R03DC019290 | Determination of the subcellular localization of adhesion G protein-coupled receptor B3 (ADGRB3) and its locations of interaction with secreted C1Q-like ligands | 000 | 1 | NIH | 11/9/2022 | $0 |
| | 2023 | 2020 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01EB023607 | A Reaction- Diffusion-Based Approach for Nucleic Acid Quantification | 000 | 5 | NIH | 11/28/2022 | $0 |
| | 2023 | 2020 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01GM051293 | Molecular Analysis of Flagellar Dynein Function | 000 | 25 | NIH | 10/27/2022 | $0 |
| | 2023 | 2019 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R21MH118986 | HIV Risk Among Young Women Workers in the Industrial Zone in Vietnam | 000 | 1 | NIH | 11/21/2022 | -$47,859 |
| | 2023 | 2018 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | RF1AG046929 | Inhibition of BACE1 for benefiting Alzheimer's patients | 000 | 6 | NIH | 10/21/2022 | $0 |
| | 2023 | 2017 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | RF1AG058261 | Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegeneration | 001 | 2 | NIH | 10/19/2022 | $6,142 |
|
| Issue Date FY: 2022 ( Subtotal = $73,936,324 ) (Continued on the next page) |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 farmington ave, asb #3 | farmington | CT | 06032-1956 | HARTFORD | USA | K01OH011596 | Surviving at Work: Reducing Workplace and Clinical Barriers to Cancer Survivors Returning to Work | 00 | 3 | CDC | 5/11/2022 | $108,000 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R21EY032741 | Targeting Citrullination in Ocular Chemical Injury | 002 | 2 | NIH | 9/19/2022 | $93,090 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R21EY032741 | Targeting Citrullination in Ocular Chemical Injury | 001 | 2 | NIH | 8/10/2022 | $246,000 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R21EY032741 | Targeting Citrullination in Ocular Chemical Injury | 000 | 1 | NIH | 5/2/2022 | $63,699 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 farmington ave, asb #3 | farmington | CT | 06032-1956 | HARTFORD | USA | U19OH012299 | CPH-NEW IV - Total Worker Health | 01 | 2 | CDC | 8/24/2022 | $0 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 farmington ave, asb #3 | farmington | CT | 06032-1956 | HARTFORD | USA | U19OH012299 | CPH-NEW IV - Total Worker Health | 01 | 2 | CDC | 8/24/2022 | $0 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 farmington ave, asb #3 | farmington | CT | 06032-1956 | HARTFORD | USA | U19OH012299 | CPH-NEW IV - Total Worker Health | 02 | 1 | CDC | 7/13/2022 | $28,628 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 farmington ave, asb #3 | farmington | CT | 06032-1956 | HARTFORD | USA | U19OH012299 | CPH-NEW IV - Total Worker Health | 00 | 2 | CDC | 6/21/2022 | $1,101,362 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 farmington ave, asb #3 | farmington | CT | 06032-1956 | HARTFORD | USA | U19OH012299 | CPH-NEW IV - Total Worker Health | 00 | 2 | CDC | 6/21/2022 | $298,638 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 farmington ave, asb #3 | farmington | CT | 06032-1956 | HARTFORD | USA | U19OH012299 | CPH-NEW IV - Total Worker Health | 02 | 2 | CDC | 9/13/2022 | $0 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 farmington ave, asb #3 | farmington | CT | 06032-1956 | HARTFORD | USA | U19OH012299 | CPH-NEW IV - Total Worker Health | 02 | 2 | CDC | 9/13/2022 | $0 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R21CA258188 | (PQ1) Mechanisms for Early Onset Colorectal Cancer | 000 | 2 | NIH | 8/9/2022 | $186,468 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01DA051671 | Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults | 000 | 2 | NIH | 2/3/2022 | $622,713 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01DA051671 | Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults | 001 | 2 | NIH | 3/18/2022 | $69,195 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R03DK128529 | The formation of kidney local microenvironment after acute kidney injury. | 001 | 2 | NIH | 3/30/2022 | $12,300 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R03DE030226 | Notch Signaling in the Regulation of TMJ Osteoarthritis | 000 | 2 | NIH | 8/17/2022 | $134,000 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01DE013986 | Oral Epithelial Cells, Candida and PMN Activation | 000 | 18 | NIH | 7/18/2022 | $564,656 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R03DK128529 | The formation of kidney local microenvironment after acute kidney injury. | 000 | 2 | NIH | 12/15/2021 | $110,700 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01CA262430 | Control of regulatory T cells by IL-17 in colorectal cancer | 000 | 2 | NIH | 5/6/2022 | $367,647 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | U01DE028520 | Individualized Assessment and Treatment Program for TMD: Coping as a Mechanism | 000 | 3 | NIH | 2/1/2022 | $645,946 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | U01DE028520 | Individualized Assessment and Treatment Program for TMD: Coping as a Mechanism | 003 | 3 | NIH | 9/3/2022 | $0 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01DK121805 | MiR-150 regulated adiose tissue B cells in obesity | 000 | 3 | NIH | 2/11/2022 | $369,000 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | U01DE028520 | Individualized Assessment and Treatment Program for TMD: Coping as a Mechanism | 001 | 3 | NIH | 5/4/2022 | $64,596 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01DK121805 | MiR-150 regulated adiose tissue B cells in obesity | 001 | 3 | NIH | 3/29/2022 | $41,000 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R00ES029116 | Impacts of modifiable factors on personal exposures and acute health | 000 | 3 | NIH | 8/10/2022 | $249,000 |
| | 2022 | 2022 | UNIVERSITY OF CONNECTICUT | 263 FARMINGTON AVE, ASB #3 | FARMINGTON | CT | 06032-1956 | HARTFORD | USA | R01GM109046 | The BMRB as an evolving resource for biomolecular structure-function research | 001 | 9 | NIH | 6/27/2022 | $84,781 |
|
